Lupin's US arm recalling 11,706 bottles of hypertension drug in US

23 Aug 2018 Evaluate

Lupin’s US subsidiary, Lupin Pharmaceuticals Inc is recalling 11,706 bottles of Lisinopril tablets, used for treating hypertension, from the American market. The product is in the strength of 10mg. 

The reason of the recall is ‘presence of foreign substance: Product complaint was received of metal contaminant observed in one tablet’. The product was distributed to distributors, mail order pharmacy and supermarkets throughout the US.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2105.85 2.55 (0.12%)
02-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.35
Dr. Reddys Lab 1255.45
Cipla 1510.95
Zydus Lifesciences 916.50
Lupin 2105.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×